Cite
Stetefeld HR, Schaal A, Scheibe F, et al. Isoflurane in (Super-) Refractory Status Epilepticus: A Multicenter Evaluation. Neurocrit Care. 2021;35(3):631-639doi: 10.1007/s12028-021-01250-z.
Stetefeld, H. R., Schaal, A., Scheibe, F., Nichtweiß, J., Lehmann, F., Müller, M., Gerner, S. T., Huttner, H. B., Luger, S., Fuhrer, H., Bösel, J., Schönenberger, S., Dimitriadis, K., Neumann, B., Fuchs, K., Fink, G. R., Malter, M. P. (2021). Isoflurane in (Super-) Refractory Status Epilepticus: A Multicenter Evaluation. Neurocritical care, 35(3), 631-639. https://doi.org/10.1007/s12028-021-01250-z
Stetefeld, Henning R, et al. "Isoflurane in (Super-) Refractory Status Epilepticus: A Multicenter Evaluation." Neurocritical care vol. 35,3 (2021): 631-639. doi: https://doi.org/10.1007/s12028-021-01250-z
Stetefeld HR, Schaal A, Scheibe F, Nichtweiß J, Lehmann F, Müller M, Gerner ST, Huttner HB, Luger S, Fuhrer H, Bösel J, Schönenberger S, Dimitriadis K, Neumann B, Fuchs K, Fink GR, Malter MP. Isoflurane in (Super-) Refractory Status Epilepticus: A Multicenter Evaluation. Neurocrit Care. 2021 Dec;35(3):631-639. doi: 10.1007/s12028-021-01250-z. Epub 2021 Jul 20. PMID: 34286464; PMCID: PMC8692280.
Copy
Download .nbib